The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Prostate Specific Antigen (PSA) Test Market In 2026 And What Value Is Projected For 2030?
The prostate specific antigen (psa) test market size has observed rapid expansion in recent years. It is forecast to grow from $4.65 billion in 2025 to $5.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The expansion witnessed in the past can be attributed to the rising implementation of psa testing in clinical settings, the development of laboratory diagnostic services, enhanced public understanding of prostate cancer screening, the availability of immunoassay-based test kits, and the inclusion of psa testing in regular health checkups.
The prostate specific antigen (psa) test market is projected for substantial expansion in the coming years. By 2030, this market is anticipated to reach $8.17 billion, demonstrating a compound annual growth rate (CAGR) of 12.0%. This growth throughout the forecast period is largely driven by advancements in high-precision PSA assay technologies, the increasing embrace of decentralized diagnostic testing, the broadening of preventive cancer screening programs, heightened investments in diagnostic automation, and an escalating need for economical screening options. Key trends shaping the forecast period encompass a greater adoption of routine PSA screening initiatives, a surging demand for point-of-care PSA testing, the expanding utilization of high-sensitivity immunoassays, a wider application of post-treatment monitoring, and an intensified emphasis on detecting cancer earlier.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp
What Major Drivers Are Influencing Demand In The Prostate Specific Antigen (PSA) Test Market?
The anticipated expansion of the prostate-specific antigen (PSA) test market is linked to the growing occurrence of prostate cancer. Prostate cancer is characterized by the formation of cancer cells in the prostate gland, which is an integral part of the male and female reproductive systems. The prostate-specific antigen (PSA) test serves as a widely utilized screening method for detecting prostate cancer in men. This test quantifies the amount of PSA in a person’s blood, aiding in timely diagnosis and evaluating risk. As an illustration, reports from March 2023 by the American Society of Clinical Oncology (ASCO), a professional oncology organization based in the US, indicated that in the US, approximately 288,300 men received a prostate cancer diagnosis, and about 34,700 individuals succumbed to the disease in 2023. Consequently, the escalating incidence of prostate cancer is stimulating the expansion of the prostate-specific antigen (PSA) test market.
What Are The Key Segments Of The Prostate Specific Antigen (PSA) Test Market?
The prostate specific antigen (psa) test market covered in this report is segmented –
1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users
Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)
What Key Developments And Trends Are Impacting The Prostate Specific Antigen (PSA) Test Market?
Key companies operating in the prostate-specific antigen (PSA) test market are prioritizing product development and launches, such as home testing kits for prostate-specific antigen (PSA), to uphold their market standing. Home testing kits are defined as self-administered diagnostic instruments that allow individuals to collect samples, perform tests, and obtain results without requiring a visit to a healthcare facility. For instance, in September 2023, Randox, an Ireland-based health and toxicology company, launched an at-home testing kit for prostate-specific antigen (PSA). This PSA home test is designed to measure PSA levels in the blood, thereby indicating potential prostate abnormalities. PSA is a protein synthesized by prostate gland cells, and elevated levels can signify various conditions, including an enlarged prostate, prostatitis, or a urinary tract infection, in addition to the possible presence of prostate cancer.
Who Are The Leading Companies Operating In The Prostate Specific Antigen (PSA) Test Market?
Major companies operating in the prostate specific antigen (psa) test market are Siemens AG, F Hoffmann La Roche AG, Abbott Laboratories, Becton Dickinson And Company, PerkinElmer Inc, Beckman Coulter Inc, Bio Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, DiaSorin SpA, OPKO Health Inc, R And D Systems Inc, Meso Scale Diagnostics LLC, Tosoh America Inc, Fujirebio Europe NV, Boditech Med Inc, DRG International Inc, Enzo Life Sciences Inc, RayBiotech Inc, Novus Biologicals LLC, Creative Diagnostics Inc, Elabscience, LifeSpan BioSciences Inc, Accuquik Inc
Read the full prostate specific antigen (psa) test market report here:
Which Region Shows The Strongest Potential For Future Growth In The Prostate Specific Antigen (PSA) Test Market?
North America was the largest region in the prostate specific antigen (PSA) test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (psa) test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Prostate Specific Antigen (PSA) Test Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp
Browse Through More Reports Similar to the Global Prostate Specific Antigen (PSA) Test Market 2026, By The Business Research Company
Prostate Cancer Drugs Global Market Report
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics Global Market Report
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model